[Pharmacological studies on clindamycin-2-palmitate (author's transl)].
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D001808:Blood Vessels / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002981:Clindamycin / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D008034:Lincomycin / Q000494:pharmacology; D008297:Male; D010169:Palmitic Acids / Q000494:pharmacology; D011188:Potassium / Q000652:urine; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000652:urine; D014599:Uterus / Q000187:drug effects
D010169:Palmitic Acids; D001464:Barium; D002981:Clindamycin; D001285:Atropine; D006632:Histamine; D012964:Sodium; D008034:Lincomycin; D000109:Acetylcholine; D011188:Potassium